Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Ecansya

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 217Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Stomach Cancer Awareness Month
    Stomach Cancer Awareness Month

    01 Nov 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/215-stomach-cancer-awareness-month

    PRESS RELEASE
    01 Nov 2025
    Share Share
    Cadonilimab Shows OS Gain In 1st-Line Advanced Gastric Cancer
    Cadonilimab Shows OS Gain In 1st-Line Advanced Gastric Cancer

    19 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/significant-os-benefit-with-cadonilimab-in-first-line-advanced-gastric-cancer-final-analysis-of-compassion-15-presented-at-esmo-2025-302588409.html

    PR NEWSWIRE
    19 Oct 2025
    Share Share
    DYPD Enhances Chemotherapy Safety To Reduce Critical Side Effects
    DYPD Enhances Chemotherapy Safety To Reduce Critical Side Effects

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dpyd-safety-update-reducing-the-risk-of-critical-or-fatal-chemotherapy-side-effects-302586745.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    HOPE in Action NanoAlvand’s Head & Neck Cancer Awareness
    HOPE in Action NanoAlvand’s Head & Neck Cancer Awareness

    27 Jul 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/209-head-neck

    PRESS RELEASE
    27 Jul 2025
    Share Share
    Processa Doses First NGC-Cap Patient In Breast Cancer Trial
    Processa Doses First NGC-Cap Patient In Breast Cancer Trial

    02 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/02/2957347/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-NGC-Cap-in-Metastatic-Breast-Cancer.html

    GLOBENEWSWIRE
    02 Oct 2024
    Share Share
    Akeso's Cadonilimab Plus Chemotherapy for Gastric Cancer Presented at 2024 AACR
    Akeso's Cadonilimab Plus Chemotherapy for Gastric Cancer Presented at 2024 AACR

    08 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oral-report--the-positive-interim-analysis-results-from-the-phase-iii-clinical-study-of-akesos--cadonilimab-pd-1ctla-4-bsab-plus-chemotherapy-as-first-line-treatment-for-advanced-gastric-cancer-presented-at-2024-aacr-302110917.html

    PR NEWSWIRE
    08 Apr 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.